# Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer

> **NCT00553254** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 55 (actual)

## Conditions studied

- Carcinoma, Non Small Cell Lung

## Interventions

- **DRUG:** PF-00299804

## Key facts

- **NCT ID:** NCT00553254
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02-05
- **Primary completion:** 2010-08-03
- **Final completion:** 2014-07-17
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00553254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00553254, "Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00553254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*